Praxis Precision Medicines (PRAX) Current Assets (2019 - 2026)

Praxis Precision Medicines' Current Assets history runs 8 years deep, the most recent figure standing at $797.8 million for Q1 2026.

• In Q1 2026, Current Assets rose 139.16% year-over-year to $797.8 million; the TTM figure through Mar 2026 stood at $797.8 million (up 139.16% YoY), while the FY2025 annual figure was $610.9 million, up 51.08% from the prior year.
• Current Assets for Q1 2026 stood at $797.8 million, up from $610.9 million in the prior quarter.
• The five-year high for Current Assets was $797.8 million in Q1 2026, with the low at $84.9 million in Q4 2023.
• The 5-year median for Current Assets is $234.5 million (2022), against an average of $277.7 million.
• The sharpest annual moves came in 2022 and 2024: Current Assets sank 61.43% in 2022, then surged 376.4% in 2024.
• Praxis Precision Medicines' Current Assets stood at $110.8 million in 2022, then dropped by 23.42% to $84.9 million in 2023, then soared by 376.4% to $404.4 million in 2024, then jumped by 51.08% to $610.9 million in 2025, then surged by 30.59% to $797.8 million in 2026.
• Business Quant data shows PRAX's Current Assets at $797.8 million in Q1 2026, $610.9 million in Q4 2025, and $273.8 million in Q3 2025.